Antigens & Molecular
Antigen detection and molecular methods have become increasingly important tools in the diagnosis of CSF infections, offering rapid and sensitive alternatives or adjuncts to traditional culture-based techniques. These advanced methods are particularly valuable in situations where time is critical, antimicrobial therapy is needed quickly, or culture results are negative or delayed
Antigen Detection Tests
- Purpose: Rapidly detect specific bacterial or fungal antigens directly in CSF
- Principle: Use antibodies that specifically bind to antigens (specific components of the pathogen)
-
Benefits
- Rapid Results: Results available in minutes to hours
- High Specificity: Antibodies are highly specific, minimizing false-positive results
- Can Detect Organisms Even if Non-Viable: Can detect antigens even in the presence of prior antibiotic therapy
- Easy to Perform: Often simpler and less technically demanding than culture
-
Types of Tests
- Latex Agglutination: Latex beads coated with antibodies against specific antigens. If the antigen is present, the beads will agglutinate (clump together)
- Enzyme Immunoassays (EIAs): Antibodies are conjugated to an enzyme that produces a color change when the antigen is present
- Immunochromatographic Assays (Lateral Flow Assays): Antibodies migrate along a strip and bind to the antigen, producing a visible line (similar to a pregnancy test)
-
Targeted Pathogens
- Streptococcus pneumoniae: Pneumococcal capsular antigen
- Haemophilus influenzae: type b: Capsular polysaccharide antigen
- Neisseria meningitidis: Capsular antigens (A, B, C, Y, W-135)
- Cryptococcus neoformans: Cryptococcal capsular antigen (CrAg)
- Group B Streptococcus: Capsular antigen
- Other pathogens: Tests are available for Staphylococcus aureus and Listeria monocytogenes
-
Limitations
- Sensitivity: Lower sensitivity than molecular methods
- Limited Number of Targets: Available for only a limited number of pathogens
- Specificity: Can sometimes have false-positive results
- May Not Provide Antibiotic Susceptibility: Only detects the antigen; not the viability of the organism
-
Procedure
- Specimen Preparation: CSF is prepared, usually by centrifugation to remove cells and debris
- Test Procedure: The test is performed according to the manufacturer’s instructions
- Result Interpretation: Positive results indicate the presence of the antigen. Negative results do not rule out infection
Molecular Methods
- Purpose: Rapidly detect specific DNA or RNA sequences of pathogens directly in CSF
- Principle: Amplify target DNA or RNA sequences to detect the presence of the organism
-
Benefits
- High Sensitivity and Specificity: PCR is very sensitive, detecting very small amounts of pathogen
- Rapid Results: Results available within hours
- Can Detect Organisms Even if Non-Culturable: Detects the genetic material, even if the organism is non-viable or inhibited by antibiotics
- Multiplexing: Multiple pathogens can be detected in a single test
- Can Provide Quantitative Results: Some methods (e.g., real-time PCR) can provide the approximate amount of DNA present
-
Types of Tests
-
Polymerase Chain Reaction (PCR)
- Most Common Method: Amplifies specific DNA sequences of pathogens
-
Procedure
- DNA is extracted from the CSF
- Specific primers (short DNA sequences) are designed to bind to a unique region of the pathogen’s DNA
- PCR amplification: the DNA is amplified (copied) in cycles, creating millions of copies of the target sequence
- Detection: The amplified DNA is then detected using various methods (gel electrophoresis, real-time PCR)
-
Real-Time PCR (qPCR)
- Quantitative Results: Measures the amount of DNA produced in each cycle, allowing for quantification of the pathogen
-
Procedure
- Similar to PCR, but uses fluorescent probes or dyes to detect and quantify the amplified DNA in real-time
- Can provide the viral load
-
Reverse Transcription PCR (RT-PCR)
- Detects RNA: Used to detect RNA viruses (e.g., enteroviruses, herpes simplex virus)
-
Procedure
- RNA is converted to DNA (reverse transcription)
- PCR is then performed on the newly synthesized DNA
-
Multiplex PCR
- Multiple Targets Simultaneously: Detects multiple pathogens in a single reaction (e.g., bacterial meningitis panel)
-
Procedure
- Multiple primer sets are used to amplify different DNA or RNA targets in the same reaction
- Different detection methods are used to distinguish the amplified products
-
Next Generation Sequencing (NGS)
- Advanced Method: Used to identify pathogens when conventional methods are non-diagnostic
-
Procedure
- Extract nucleic acids from the sample
- Sequencing libraries are prepared and sequenced
- Sequencing data are analyzed to identify pathogens
-
Polymerase Chain Reaction (PCR)
-
Targeted Pathogens
-
Bacteria
- Streptococcus pneumoniae
- Haemophilus influenzae
- Neisseria meningitidis
- Listeria monocytogenes
- Escherichia coli
- Other Enterobacteriaceae
-
Viruses
- Enteroviruses (e.g., poliovirus, coxsackievirus)
- Herpes simplex virus (HSV)
- Varicella-zoster virus (VZV)
- Cytomegalovirus (CMV)
- West Nile virus
-
Fungi
- Cryptococcus neoformans
-
Parasites
- Naegleria fowleri
-
Bacteria
-
Limitations
- Cost: More expensive than traditional culture
- Requires Specialized Equipment and Training
- Cannot Always Provide Antibiotic Susceptibility Information: Molecular tests can identify the presence of genetic markers for resistance
- Primer Design: Requires knowledge of the pathogen’s genome to design primers
- May Detect Non-Viable Organisms: Can detect DNA from dead organisms, which may not be clinically significant
-
Procedure
- Specimen Preparation: CSF is prepared, usually by centrifugation
- Nucleic Acid Extraction: DNA or RNA is extracted from the CSF
- Amplification: PCR or RT-PCR is performed
- Detection and Result Interpretation: The amplified DNA is detected, and results are interpreted
Role in Diagnosis and Management
- Rapid Diagnosis: Enables quick confirmation of the presence of a pathogen, allowing for rapid initiation of appropriate antimicrobial therapy, or supportive care
- Improved Outcomes: Early and targeted therapy improves patient outcomes
- Identification of Non-Culturable Organisms: Can identify pathogens when culture is negative due to prior antibiotic use or fastidious organisms (e.g., Listeria monocytogenes)
- Multiplex Testing: Allows for simultaneous detection of multiple pathogens, which is particularly useful in cases of suspected mixed infections, or when clinical presentation is unclear
- Monitoring Treatment Response: Quantitative PCR can be used to monitor the response to antiviral therapy (e.g., HSV encephalitis)
- Antimicrobial Stewardship: Guides antibiotic choices and helps with de-escalation
Key Terms
- Antigen: A substance (e.g., protein, polysaccharide) that triggers an immune response
- Antibody: A protein produced by the immune system that recognizes and binds to a specific antigen
- Antigen Detection Test: A test that detects the presence of a specific antigen
- Latex Agglutination: A type of antigen detection test
- Enzyme Immunoassay (EIA): A type of antigen detection test
- Immunochromatographic Assay (Lateral Flow Assay): A type of antigen detection test
- Molecular Method: A method that detects the presence of specific DNA or RNA sequences
- Polymerase Chain Reaction (PCR): A molecular method to amplify specific DNA sequences
- Primer: A short DNA sequence that binds to a specific region of DNA
- Real-Time PCR (qPCR): A PCR method that quantifies DNA during amplification
- Reverse Transcription PCR (RT-PCR): A PCR method that detects RNA
- Multiplex PCR: A PCR method that detects multiple targets simultaneously
- Nucleic Acid Extraction: The process of isolating DNA or RNA from a sample
- Sensitivity: The ability of a test to correctly identify a pathogen
- Specificity: The ability of a test to correctly identify the absence of a pathogen
- False Positive: A test result that indicates the presence of a pathogen when it is not actually present
- False Negative: A test result that indicates the absence of a pathogen when it is actually present
- Viral Load: The amount of virus present in a sample
- Antimicrobial Therapy: The use of antibiotics or antifungals to treat infections
- Amplification: The process of making multiple copies of a DNA or RNA sequence
- Target: The specific DNA or RNA sequence that is amplified by PCR
- Quellung Reaction: (capsular swelling). Serotyping
- Enriched Media: Culture media containing extra nutrients to support the growth of fastidious microorganisms
- Fastidious Organism: A microorganism with complex nutritional requirements